Soleus Capital Management, L.P. Pliant Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $607,020 - $1.02 Million	33,500 New	33,500 $607,000
Q3 2022 Nov 14, 2022	SELL	$7.67 - $24.23 $3.6 Million - $11.4 Million	-468,800 Reduced 95.67%	21,200 $443,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $1.03 Million - $2.19 Million	250,000 Added 104.17%	490,000 $3.93 Million
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $1.68 Million - $3.38 Million	240,000 New	240,000 $1.68 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.